Association Between miR-146a rs2910164 Polymorphism and Breast Cancer Susceptibility: An Updated Meta-Analysis of 9545 Cases and 10030 Controls

Title:Association Between miR-146a rs2910164 Polymorphism and Breast Cancer Susceptibility: An Updated Meta-Analysis of 9545 Cases and 10030 Controls

Volume: 10 Issue: 3

Author(s): Abdolkarim Moazeni-Roodi, Sajjad Aftabi, Sahel Sarabandi, Shima Karami, Mohammad Hashemi*, Saeid Ghavami*Mohsen Taheri*

Affiliation:

• Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan,Iran
• Genetics of Non-communicable Disease Research Center, Zahedan University of Medical Sciences, Zahedan, Iran

• Department of Human Anatomy and Cell Science, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg,Canada
• Research Institute in Oncology and Hematology, CancerCare Manitoba, University of Manitoba, Winnipeg, Canada

• Genetics of Non-communicable Disease Research Center, Zahedan University of Medical Sciences, Zahedan,Iran
• Department of Genetic, School of Medicine, Zahedan University of Medical Sciences, Zahed an, Iran

Keywords: Breast cancer, meta-analysis, mir-146a, polymorphism, odd ratios, single nucleotide polymorphisms (SNPs

Abstract:

Background: Several studies have reported a possible association of miR-146a rs2910164 polymorphism with Breast Cancer (BC) development. However, the correlation between this polymorphism and susceptibility to BC is under debate. The current meta-analysis was designed and performed to more conclusively evaluate the miR-146a rs2910164 polymorphism and its potential link to BC.

Methods: Our team has selected eligible studies (published up to October 2, 2020) from several electronic databases, including Web of Science, PubMed, Scopus and Google Scholar. A total number of 9,545 BC cases and 10,030 controls extracted from 26 eligible articles were included in this study. We utilized pooled Odds Ratios (ORs) as well as 95% confidence intervals (95% CIs) under five genetic models for quantitative estimation of any possible association between miR-146a rs2910164 polymorphism and BC.

Results: Based on this meta-analysis, our findings suggest that there is no significant association between miR-146a rs2910164 polymorphism and BC risk. However, stratified analysis revealed that the rs2910164 polymorphism significantly increased the risk of BC in hospital-based studies using the homozygous genetic model (OR=1.37, 95%CI=1.01-1.86, p=0.043, CC vs. GG). Neither Asian nor Caucasian populations showed any significant association between rs2910164 polymorphism and BC susceptibility.

Conclusion: In summary, our findings suggest that BC development is not associated with miR-146a rs2910164 polymorphism. However, larger ingenious future investigations might be needed for a more precise estimation of any association between miR-146a rs2910164 polymorphism and BC.

Cite this article as:

Moazeni-Roodi Abdolkarim, Aftabi Sajjad , Sarabandi Sahel , Karami Shima , Hashemi Mohammad *, Ghavami Saeid *, Taheri Mohsen *, Association Between miR-146a rs2910164 Polymorphism and Breast Cancer Susceptibility: An Updated Meta-Analysis of 9545 Cases and 10030 Controls, MicroRNA 2021; 10 (3) . https://dx.doi.org/10.2174/2211536610666210707113229